1,3-di-(4-imidazolino-2-methoxyphenoxy)propane has been researched along with butamidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karplus, M; So, SS | 1 |
| Allen, MA; Geratz, JD; Hall, JE; Jones, SK; Morrison, SD; Ohemeng, KA; Reddy, VV; Tidwell, RR | 1 |
2 other study(ies) available for 1,3-di-(4-imidazolino-2-methoxyphenoxy)propane and butamidine
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 2. Applications.
Topics: Cholinesterase Inhibitors; Dopamine beta-Hydroxylase; Drug Design; Enzyme Inhibitors; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Molecular Conformation; Molecular Structure; Neural Networks, Computer; Phosphorylases; Receptors, Aryl Hydrocarbon; Static Electricity; Structure-Activity Relationship | 1997 |
Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia.
Topics: Animals; Antifungal Agents; Dose-Response Relationship, Drug; Male; Pentamidine; Pneumonia, Pneumocystis; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1990 |